Skip to content

Clinical trials

Schizophrenia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: United Kingdom Clear all

109 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20045
20053
20063
20073
20082
20094
20104
20117
20124
20135
20149
20155
20165
20178
20184
20196
20206
20213
20226
20231
20245
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed82
Recruiting9
Unknown status9
Terminated8
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
King's College London16
GlaxoSmithKline9
Otsuka Pharmaceutical Development & Commercialization, Inc.8
Janssen-Cilag International NV5
University of Manchester5
Autifony Therapeutics Limited4
Boehringer Ingelheim4
Hoffmann-La Roche4
AstraZeneca3
Alkermes, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia109
Psychotic Disorders36
Bipolar Disorder12
Mental Disorders6
Anxiety Disorders4
Depressive Disorder4
Cognitive Dysfunction3
Inflammation3
Major Depressive Disorder3
Personality Disorders3

Trials

Showing 1 to 25 of 109. Each trial links to its page on Pharma Observatory.

9 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.